ArticleMolecular therapy oncolytics2021

IRGM promotes melanoma cell survival through autophagy and is a promising prognostic biomarker for clinical application.

Linlu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.